Hongxia Wang
Fudan University Principal Investigator Biyun Wang , Chief physician Fudan University · Fudan University · Fudan Cancer Hospital
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Registry trials as an overall official
17
all conditions, ClinicalTrials.gov
NIH grants tied to them
0
NIH RePORTER
Trial papers in rhabdomyosarcoma
0
PubMed author-name match
Trials
Studies that name Hongxia Wang as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 12:00 UTC. Open this list on ClinicalTrials.gov
- Ph3NCT07615751 · Pyrotinib and Trastuzumab Combined With Dalpiciclib Versus Combined With Docetaxel in Advanced HER2-Positive Breast CancerFudan University · recruiting · Breast Cancer · principal investigator
- Ph1NCT07376707 · A Phase 1 Study of TGI-5 as Monotherapy and in Combination With Nivolumab in Subjects With Locally Advanced/Metastatic Solid TumorsHefei TG ImmunoPharma Co., Ltd. · recruiting · CRC (Colorectal Cancer), Melanoma (Skin Cancer), HCC - Hepatocellular Carcinoma · principal investigator
- Ph2NCT07182721 · SKB264 Plus Inetetamab in HER2-Positive Metastatic Breast Cancer Patients Progressing After T-DXd TreatmentFudan University · recruiting · HER2-positive, Unresectable, Locally Advanced or Metastatic Breast Cancer, SKB264, Inetetamab · principal investigator
- Ph2NCT07041437 · Study of SHR-A2102 Combined Other Antitumor Drugs in Advanced Breast CancerFudan University · not yet recruiting · Advanced Breast Cancer · principal investigator
- Ph2NCT06889610 · A Phase II Clinical Study of Multimodal Ablation Combined With Systemic Drug Therapy for Advanced Solid Tumors.Fudan University · recruiting · Triple Negative Breast Cancer Metastatic, Melanoma Metastatic, Colorectal Cancer Metastatic · principal investigator
- Early Ph1NCT06718946 · Study on the Safety and Efficacy of Intravenous Administration of IDOV-SAFETM in the Treatment of Advanced Solid TumorsFudan University · recruiting · Advanced Malignant Solid Tumor · principal investigator
- Ph1/Ph2NCT06718933 · Study of SHR-A1811 Combined With Pyrotinib and Bevacizumab in Advanced Breast Cancer With Brain MetastasisFudan University · recruiting · Breast Cancer Metastatic, Breast Cancer Brain Metastases · principal investigator
- Early Ph1NCT06713148 · Study on the Safety and Efficacy of Intratumoral Administration of IDOV-SAFETM in the Treatment of Advanced Solid TumorsFudan University · not yet recruiting · Advanced Malignant Solid Tumor · principal investigator
- Ph2NCT06684327 · Multi-cohort, Single-arm Phase II Study of Albumin-paclitaxel, Ifosfamide, and Cisplatin in the Treatment of Rare Advanced TumorsFudan University · recruiting · Paget Disease, Extramammary, Rhabdomyosarcoma, Testicular Cancer · study director
- Ph2NCT06683846 · Ivonescimab in the Treatment of Multiple Advanced TumorsFudan University · recruiting · Pheochromocytoma/Paraganglioma, Rhabdomyosarcoma, Paget Disease, Extramammary · principal investigator
- Ph2NCT06551051 · ADC-induced Neurotoxicity Treated With DuloxetineFudan University · unknown · Solid Tumour · principal investigator
- Ph2NCT06470672 · Study of SHR-A1921 Combined Adebrelimab in HR-positive, HER2-negative Advanced Breast CancerFudan University · unknown · Advanced Breast Cancer, Hormone-receptor-positive Breast Cancer, Human Epidermal Growth Factor 2 Negative Carcinoma of Breast · principal investigator
- Ph1NCT06426680 · A Study of the ILB-3101 in Patients with Advanced Solid TumorsInnolake Biopharm · recruiting · Advanced Solid Tumor · principal investigator
- Early Ph1NCT05831033 · Safety and Efficacy of an Autologous Tumor Infiltrating Lymphocyte (TIL) Therapy in Patients with Advanced Solid TumorsShanghai General Hospital, Shanghai Jiao Tong University School of Medicine · recruiting · Solid Tumor · principal investigator
- N/ANCT04676620 · Comparison of Anterior Corneal Optical Aberration Induced by CK and Hyperopic LASIKWang Hongxia · unknown · Refractive Error · study director
- N/ANCT04666870 · Axis Length and Its Relationship With Refractive Error in Chinese University StudentsWang Hongxia · completed · Refractive Error - Myopia Axial · study director
- Early Ph1NCT02929797 · Immunotherapy of CD8+NKG2D+ AKT Cell With Chemotherapy to Pancreatic CancerShanghai General Hospital, Shanghai Jiao Tong University School of Medicine · unknown · Pancreatic Ductal Adenocarcinoma · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 12:00 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in rhabdomyosarcoma.